פלאג'יל 500 מ"ג ישראל - עברית - Ministry of Health

פלאג'יל 500 מ"ג

sanofi - aventis israel ltd - metronidazole 500 mg - pessary - metronidazole - trichomoniasis.

מטרוג'יל ישראל - עברית - Ministry of Health

מטרוג'יל

teva pharmaceutical indust.ltd - metronidazole 250 mg - tablets - metronidazole - for the treatment of : - symptomatic trichomoniasis in women and men when the presence of the trichomonad has been confirmed by appropriate laboratory procedures. - asymptomatic trichomoniasis in women when the organism is associated with endocervicitis cervicitis or cervical erosion. - asymptomatic consort. - acute intestinal amebiasis (amebic dysentery) and amebic liver absess. - anaerobic bacterial infections caused by susceptible anaerobic bacteria.

פלאג'יל 250 מ"ג ישראל - עברית - Ministry of Health

פלאג'יל 250 מ"ג

sanofi - aventis israel ltd - metronidazole 250 mg - film coated tablets - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

mesotheraphy gun ישראל - עברית - Ministry of Health

mesotheraphy gun

gazit/derma hope ltd. - אחר - אקדח למזותרפיה

Microparticles For Embolization ישראל - עברית - Ministry of Health

microparticles for embolization

גאמידה בע"מ - רופא - חלקיקים המיועדים לאמבוליזציה של כלי דם

microprobe surgical laser endoscopy syst ישראל - עברית - Ministry of Health

microprobe surgical laser endoscopy syst

אלפא-נטו בע"מ - רופא - מערכות אנדוסקופיות לרפואת עיניים הכוללות מערכות לייזר , אנדוסקופים , פרובים ואביזרים נלווים

אימנד 150 מ"ג IV ישראל - עברית - Ministry of Health

אימנד 150 מ"ג iv

merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.